Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T14:16:39.253Z.
Calculation as of: 2026-10-06T14:16:39.253Z.
Quote observation: 2026-10-06T14:15:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b4a4fa98aa52f375fdc5874331a43a09dc7975e501838f67450551c218d6975f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-03-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
48.59x
EV/FCF RATIO AVG 3Y
48.59x
EV/FCF RATIO AVG 5Y
48.59x
EV/FCF RATIO AVG 10Y
10.48x
EV/FCF RATIO AVG 15Y
9.82x
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
EyePoint Pharmaceuticals, Inc.
Market Cap
$259.49M
EV/FCF Ratio
N/A
TTM Avg
48.59x
3Y Avg
48.59x
5Y Avg
48.59x
Market Cap
$257.13M
EV/FCF Ratio
430.66x
TTM Avg
210.95x
3Y Avg
227.91x
5Y Avg
182.13x
Market Cap
$261.43M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$252.11M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$263.15M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$271.78M
EV/FCF Ratio
N/A
TTM Avg
1.69x
3Y Avg
1.69x
5Y Avg
1.69x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $259.49M | N/A | 48.59x | 48.59x | 48.59x |
| Century Therapeutics, Inc. (IPSC)vs › | $257.15M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $260.03M | N/A | 4.58x | 4.76x | 4.76x |
| Anika Therapeutics, Inc. (ANIK)vs › | $257.13M | 430.66x | 210.95x | 227.91x | 182.13x |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.43M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $252.11M | N/A | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $263.15M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $243.85M | N/A | N/A | N/A | N/A |
| Indaptus Therapeutics, Inc. (INDP)vs › | $271.78M | N/A | 1.69x | 1.69x | 1.69x |
| Aurora Cannabis Inc. (ACB)vs › | $274.71M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2024-03-08 | 87.80x |
| 2024-03-07 | 91.59x |
| 2024-03-06 | 93.38x |
| 2024-03-05 | 92.67x |
| 2024-03-04 | 94.09x |
| 2024-03-01 | 102.79x |
| 2024-02-29 | 99.50x |
| 2024-02-28 | 101.45x |
| 2024-02-27 | 105.57x |
| 2024-02-26 | 96.75x |
| 2024-02-23 | 96.75x |
| 2024-02-22 | 94.88x |
| 2024-02-21 | 97.08x |
| 2024-02-20 | 101.58x |
| 2024-02-16 | 104.08x |
| 2024-02-15 | 107.28x |
| 2024-02-14 | 106.61x |
| 2024-02-13 | 109.57x |
| 2024-02-12 | 109.90x |
| 2024-02-09 | 106.12x |
| 2024-02-08 | 107.45x |
| 2024-02-07 | 108.49x |
| 2024-02-06 | 106.41x |
| 2024-02-05 | 101.91x |
| 2024-02-02 | 105.70x |
| 2024-02-01 | 104.91x |
| 2024-01-31 | 98.33x |
| 2024-01-30 | 93.79x |
| 2024-01-29 | 97.42x |
| 2024-01-26 | 96.42x |
| 2024-01-25 | 89.88x |
| 2024-01-24 | 85.89x |
| 2024-01-23 | 89.92x |
| 2024-01-22 | 86.05x |
| 2024-01-19 | 79.14x |
| 2024-01-18 | 81.39x |
| 2024-01-17 | 77.27x |
| 2024-01-16 | 80.97x |
| 2024-01-12 | 80.97x |
| 2024-01-11 | 70.98x |
| 2024-01-10 | 70.44x |
| 2024-01-09 | 75.60x |
| 2024-01-08 | 77.56x |
| 2024-01-05 | 71.15x |
| 2024-01-04 | 69.19x |
| 2024-01-03 | 73.48x |
| 2024-01-02 | 79.97x |
| 2023-12-29 | 82.43x |
| 2023-12-28 | 84.30x |
| 2023-12-27 | 86.68x |
| 2023-12-26 | 84.55x |
| 2023-12-22 | 80.22x |
| 2023-12-21 | 72.77x |
| 2023-12-20 | 66.82x |
| 2023-12-19 | 69.49x |
| 2023-12-18 | 65.11x |
| 2023-12-15 | 67.61x |
| 2023-12-14 | 71.03x |
| 2023-12-13 | 71.52x |
| 2023-12-12 | 65.32x |
| 2023-12-11 | 69.36x |
| 2023-12-08 | 65.95x |
| 2023-12-07 | 74.40x |
| 2023-12-06 | 66.78x |
| 2023-12-05 | 60.08x |
| 2023-12-04 | 62.58x |
| 2023-12-01 | 13.75x |
| 2023-11-30 | 12.25x |
| 2023-11-29 | 12.38x |
| 2023-11-28 | 11.58x |
| 2023-11-27 | 11.83x |
| 2023-11-24 | 11.79x |
| 2023-11-22 | 11.21x |
| 2023-11-21 | 11.71x |
| 2023-11-20 | 15.66x |
| 2023-11-17 | 13.92x |
| 2023-11-16 | 11.96x |
| 2023-11-15 | 14.08x |
| 2023-11-14 | 13.17x |
| 2023-11-13 | 12.87x |
| 2023-11-10 | 12.87x |
| 2023-11-09 | 13.71x |
| 2023-11-08 | 15.33x |
| 2023-11-07 | 18.08x |
| 2023-11-06 | 17.99x |
| 2023-11-03 | 13.39x |
| 2023-11-02 | 11.93x |
| 2023-11-01 | 11.77x |
| 2023-10-31 | 7.88x |
| 2023-10-30 | 6.90x |
| 2023-10-27 | 7.50x |
| 2023-10-26 | 8.20x |
| 2023-10-25 | 8.90x |
| 2023-10-24 | 12.25x |
| 2023-10-23 | 10.22x |
| 2023-10-20 | 12.55x |
| 2023-10-19 | 12.60x |
| 2023-10-18 | 13.04x |
| 2023-10-17 | 14.32x |
| 2023-10-16 | 14.92x |
| 2023-10-13 | 14.51x |
| 2023-10-12 | 14.51x |
| 2023-10-11 | 15.97x |
| 2023-10-10 | 16.58x |
| 2023-10-09 | 16.54x |
| 2023-10-06 | 16.13x |
| 2023-10-05 | 15.65x |
| 2023-10-04 | 13.93x |
| 2023-10-03 | 14.28x |
| 2023-10-02 | 13.55x |
| 2023-09-29 | 14.16x |
| 2023-09-28 | 14.19x |
| 2023-09-27 | 14.70x |
| 2023-09-26 | 14.19x |
| 2023-09-25 | 14.28x |
| 2023-09-22 | 15.62x |
| 2023-09-21 | 15.30x |
| 2023-09-20 | 16.00x |
| 2023-09-19 | 18.58x |
| 2023-09-18 | 19.47x |
| 2023-09-15 | 22.08x |
| 2023-09-14 | 23.74x |
| 2023-09-13 | 23.14x |
| 2023-09-12 | 24.60x |
| 2023-09-11 | 25.81x |
| 2023-09-08 | 20.65x |
| 2023-09-07 | 20.75x |
| 2023-09-06 | 19.82x |
| 2023-09-05 | 18.77x |
| 2023-09-01 | 22.21x |
| 2023-08-31 | 20.27x |
| 2023-08-30 | 23.93x |
| 2023-08-29 | 22.15x |
| 2023-08-28 | 25.81x |
| 2023-08-25 | 24.73x |
| 2023-08-24 | 25.36x |
| 2023-08-23 | 25.78x |
| 2023-08-22 | 35.27x |
| 2023-08-21 | 37.62x |
| 2023-08-18 | 34.25x |
| 2023-08-17 | 30.78x |
| 2023-08-16 | 32.53x |
| 2023-08-15 | 33.90x |
| 2023-08-14 | 33.93x |
| 2023-08-11 | 33.93x |
| 2023-08-10 | 33.36x |
| 2023-08-09 | 30.52x |
| 2023-08-08 | 28.10x |
| 2023-08-07 | 28.10x |
| 2016-02-09 | 7.82x |
| 2016-02-08 | 8.31x |
| 2016-02-05 | 8.86x |
| 2016-02-04 | 9.04x |
| 2016-02-03 | 8.74x |
| 2016-02-02 | 8.92x |
| 2016-02-01 | 9.26x |
| 2016-01-29 | 8.95x |
| 2016-01-28 | 9.07x |
| 2016-01-27 | 9.26x |
| 2016-01-26 | 9.90x |
| 2016-01-25 | 9.47x |
| 2016-01-22 | 9.44x |
| 2016-01-21 | 9.17x |
| 2016-01-20 | 9.68x |
| 2016-01-19 | 9.20x |
| 2016-01-15 | 9.10x |
| 2016-01-14 | 9.23x |
| 2016-01-13 | 9.38x |
| 2016-01-12 | 9.96x |
| 2016-01-11 | 10.48x |
| 2016-01-08 | 10.63x |
| 2016-01-07 | 11.76x |
| 2016-01-06 | 11.15x |
| 2016-01-05 | 12.22x |
| 2016-01-04 | 13.20x |
| 2015-12-31 | 13.26x |
| 2015-12-30 | 12.98x |
| 2015-12-29 | 12.80x |
| 2015-12-28 | 13.01x |
| 2015-12-24 | 11.88x |
| 2015-12-23 | 12.40x |
| 2015-12-22 | 12.25x |
| 2015-12-21 | 9.84x |
| 2015-12-18 | 9.81x |
| 2015-12-17 | 10.60x |
| 2015-12-16 | 10.08x |
| 2015-12-15 | 9.26x |
| 2015-12-14 | 9.26x |
| 2015-12-11 | 9.71x |
| 2015-12-10 | 9.90x |
| 2015-12-09 | 9.99x |
| 2015-12-08 | 10.42x |
| 2015-12-07 | 10.11x |
| 2015-12-04 | 10.45x |
| 2015-12-03 | 10.36x |
| 2015-12-02 | 10.45x |
| 2015-12-01 | 10.66x |
| 2015-11-30 | 10.39x |
| 2015-11-27 | 10.51x |
| 2015-11-25 | 10.45x |
| 2015-11-24 | 10.11x |
| 2015-11-23 | 9.99x |
| 2015-11-20 | 10.20x |
| 2015-11-19 | 10.17x |
| 2015-11-18 | 10.33x |
| 2015-11-17 | 9.99x |
| 2015-11-16 | 10.08x |
| 2015-11-13 | 9.99x |
| 2015-11-12 | 9.99x |
| 2015-11-11 | 10.05x |
| 2015-11-10 | 10.08x |
| 2015-11-09 | 10.36x |
| 2015-11-06 | 9.14x |
| 2015-11-05 | 9.52x |
| 2015-11-04 | 9.40x |
| 2015-11-03 | 9.26x |
| 2015-11-02 | 9.31x |
| 2015-10-30 | 9.26x |
| 2015-10-29 | 9.23x |
| 2015-10-28 | 9.29x |
| 2015-10-27 | 9.00x |
| 2015-10-26 | 9.31x |
| 2015-10-23 | 9.34x |
| 2015-10-22 | 9.49x |
| 2015-10-21 | 9.37x |
| 2015-10-20 | 9.72x |
| 2015-10-19 | 9.55x |
| 2015-10-16 | 9.63x |
| 2015-10-15 | 9.23x |
| 2015-10-14 | 8.76x |
| 2015-10-13 | 8.97x |
| 2015-10-12 | 9.14x |
| 2015-10-09 | 9.11x |
| 2015-10-08 | 8.91x |
| 2015-10-07 | 8.91x |
| 2015-10-06 | 9.14x |
| 2015-10-05 | 9.20x |
| 2015-10-02 | 8.79x |
| 2015-10-01 | 8.53x |
| 2015-09-30 | 8.70x |
| 2015-09-29 | 8.44x |
| 2015-09-28 | 9.11x |
| 2015-09-25 | 8.30x |
| 2015-09-24 | 8.59x |
| 2015-09-23 | 8.79x |
| 2015-09-22 | 8.85x |
| 2015-09-21 | 9.00x |
| 2015-09-18 | 9.34x |
| 2015-09-17 | 9.49x |
| 2015-09-16 | 9.02x |
| 2015-09-15 | 9.63x |
| 2015-09-14 | 9.23x |
| 2015-09-11 | 9.23x |
| 2015-09-10 | 8.50x |
| 2015-09-09 | 8.70x |
| 2015-09-08 | 8.64x |
| 2015-09-04 | 8.38x |
| 2015-09-03 | 8.38x |
| 2015-09-02 | 8.32x |
| 2015-09-01 | 8.32x |
Showing the most recent 260 of 646 data points. The chart above shows the full history.
